Design, Synthesis and Molecular Docking Studies of Novel Isoxazole Analogs as HIV-1 and TB Inhibitors

Authors(4) :-Chithra V. S, Abbs Fen Reji. T. F, Brindha J., Jani Metilda

HIV is a major threat to public health care systems since the virus can mutate rapidly and develop drug-resistant variants. Chemotherapy is more complicated when accompanied by opportunistic infections like TB. Toward this objective, a series of benzimidazolyl isoxazoles were synthesized and molecular docking studies were performed using PyRx virtual screening tool in the active site of two different proteins namely HIV-1 reverse transcriptase (PDB code 1RT2) and Mycobacterium tuberculosis-CYP450 (PDB code 1EA1) to study the binding mode of these analogs. The hydrophobicity and ADME properties were found to be critical for activity. The results reveal that all the compounds can be used orally as good drug candidates and the docking scores were comparable to the standard compounds. compound C1 was found as the highest active against both the proteins.

Authors and Affiliations

Chithra V. S
Department of Chemistry & Research Centre, Nesamony Memorial Christian College, Marthandam, Tamilnadu, India
Abbs Fen Reji. T. F
Department of Chemistry & Research Centre, Nesamony Memorial Christian College, Marthandam, Tamilnadu, India
Brindha J.
Department of Chemistry & Research Centre, Nesamony Memorial Christian College, Marthandam, Tamilnadu, India
Jani Metilda
Department of Chemistry & Research Centre, Nesamony Memorial Christian College, Marthandam, Tamilnadu, India

Reverse Transcriptase, Docking, PDB, ADME, Lipinski rule.

  1. UNAIDS(2017) ‘Fact sheet 2017’
  2. Swastika Ganguly, Geeta Yadav. 2013. Molecular docking studies of novel benzimidazole analogs as HIV-1-RT inhibitors with broad spectrum chemotherapeutic properties; Int.J.Drug Design. Discovery.  4(4): 1193-1213.
  3. G. Reiner, Villavicencio, B. Junie, Billones. 2009.  Computational studies of dipyridodiazepinones as Human Immunodeficiency Virus ( HIV) Reverse Transcriptase inhibitors.  Philippine.J.Sci. 138 (1): 105-113.
  4. Untiwa Ounthaisong, Prasan Tangyuenyongwatana. 2017 . Cross docking study of flavanoids against tyrosinase enzymes using PyRx 0.8 virtual screening tool. TJPS, 41, 189-192.
  5. D.Vivitri.  Prasasty,  Ignatia Eveline, Ekaristy, J. Noya. 2017.  Potential natural inhibitor bioactivities against high-risk HPV-16, HPV-18 and HPV-52 of E6 oncoprotein through molecular docking. (2)2: 39-45
  6. Y. Chen, B. Shoichet, R. Bonnet. 2005.  Structure, function, and inhibition along the reaction coordinate of CTX-M ?-lactamases. J.Am.Chem.Soc. 127(15): 5423-5434.
  7. Sainath Namthabad, Estari Mamidala. 2014.  Molecular docking of HIV-1 protease using alkaloids from Tinospora cordifolia. Int. J. Res.App. 1(1): 12-16

Publication Details

Published in : Volume 3 | Issue 6 | September-October 2017
Date of Publication : 2017-10-31
License:  This work is licensed under a Creative Commons Attribution 4.0 International License.
Page(s) : 460-464
Manuscript Number : IJSRSET173692
Publisher : Technoscience Academy

Print ISSN : 2395-1990, Online ISSN : 2394-4099

Cite This Article :

Chithra V. S, Abbs Fen Reji. T. F, Brindha J., Jani Metilda, " Design, Synthesis and Molecular Docking Studies of Novel Isoxazole Analogs as HIV-1 and TB Inhibitors, International Journal of Scientific Research in Science, Engineering and Technology(IJSRSET), Print ISSN : 2395-1990, Online ISSN : 2394-4099, Volume 3, Issue 6, pp.460-464, September-October-2017.
Journal URL : http://ijsrset.com/IJSRSET173692

Follow Us

Contact Us